Recorlev (levoketoconazole), Strongbridge Biopharma's oral investigational therapy for endogenous Cushing's syndrome, resulted in sustained improvements in cortisol and glycemic control in patients with Cushing...
Insulin resistance causes type 2 diabetes, which is increasing worldwide. Insulin resistance is also a major factor in the pathogenesis of cardiometabolic diseases....
SAN ANTONIO - A partnership between UT Health San Antonio, University Health and Texas Biomed shows promising, if not remarkable, results from a new...